Acesso livre
Acesso livre

Covid-19 (Temas de Saúde Pública)

Miocardite após vacina de mRNA contra COVID-19: uma série de casos e a determinação das taxas de incidência.

8 Nov, 2021 | 12:41h

Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination – Clinical Infectious Diseases

Conteúdos relacionados:

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

Vacinação contra COVID-19 em gestantes, crianças, pacientes imunocomprometidos, pessoas com histórico de alergia ou infecção prévia por SARS-CoV-2: visão geral das recomendações atuais e evidências pré e pós-marketing da eficácia e da segurança das vacinas.

8 Nov, 2021 | 12:40h

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety – Drug Safety

Ponto de vista | Crianças e COVID-19 nas escolas.

8 Nov, 2021 | 12:38h

Children and COVID-19 in schools – Science

Conteúdos relacionados:

Instead of quarantine for Covid-exposed students, some schools are trying test-to-stay.

Cluster RCT: Daily contact testing of school-based contacts was non-inferior to self-isolation for control of COVID-19 transmission.

Kids are losing school days to quarantines. Here’s a way to keep them in classrooms – “Test-to-stay could dramatically reduce close contact quarantines”.

Opinion | Data from routine Covid testing can help schools stay open this year.

CDC Report: Schools without mask requirements were more likely to have Covid-19 outbreaks.

Perspective | Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain.

COVID and schools: the evidence for reopening safely.

COVID studies note online learning stress, fewer cases in schools with protocols

Alemanha oferece doses de reforço de vacina contra Covid-19 a todos em meio a um aumento de casos “muito preocupante”.

8 Nov, 2021 | 12:37h

Germany offers booster shots to everyone amid ‘very worrying’ surge in cases – CNN

Estudo compara a queda da efetividade das vacinas da Moderna, da Pfizer e da Janssen, além das consequências para a mortalidade.

5 Nov, 2021 | 17:21h

Estudo original: SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 – Science

Comunicado de imprensa: Breakthrough Infection Study Compares Decline in Vaccine Effectiveness and Consequences for Mortality – Public Health Institute

 

Comentário no Twitter

 

Efeitos da pandemia de Covid-19 na expectativa de vida e na mortalidade prematura em 2020 – Esta análise mostrou que houve mais de 28 milhões de anos a mais de vida perdidos em 2020 em 31 países.

5 Nov, 2021 | 17:20h

Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries – The BMJ

Conteúdos relacionados:

Global Covid-19 deaths surpass five million.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Revisão | Transmissão do SARS-CoV-2 pelo ar em ambientes fechados é uma ameaça que pode ser combatida com ciência.

5 Nov, 2021 | 17:17h

SARS-CoV-2 indoor air transmission is a threat that can be addressed with science – Proceedings of the National Academies of Sciences

Conteúdos relacionados:

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

Editorial: Covid-19 has redefined airborne transmission

Covid-19: What do we know about airborne transmission of SARS-CoV-2?

Real-world data show that filters clean COVID-causing virus from air.

Perspective | The plan to stop every respiratory virus at once – “The benefits of ventilation reach far beyond the coronavirus. What if we stop taking colds and flus for granted, too?”

Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission.

We studied how to reduce airborne COVID spread in hospitals. Here’s what we learnt.

Report: Improved ventilation essential to safe use of buildings and public spaces, say leading engineers.

WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

Guidance: Using Ventilation and filtration to reduce aerosol transmission of COVID-19 in long-term care homes

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols.

 

Comentário no Twitter

 

Debate: os comprovantes de vacinação são uma alternativa válida ao lockdown?

5 Nov, 2021 | 17:15h

Are vaccine passports and covid passes a valid alternative to lockdown? – The BMJ

Comunicado de imprensa: Covid passes: the best way of preventing another lockdown or a threat to civil freedoms and rights? – BMJ

Reino Unido aprova a pílula antiviral da Merck para COVID-19.

5 Nov, 2021 | 17:14h

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first – NPR

Conteúdos relacionados:

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

OMS aprova o uso emergencial da vacina indiana Covaxin.

4 Nov, 2021 | 12:09h

WHO issues emergency use listing for eighth COVID-19 vaccine – World Health Organization

Comentários:

WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution – Health Policy Watch

WHO green-lights India’s COVID vaccine as global cases rise – CIDRAP

 

Comentário no Twitter (fio – clique para saber mais)

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.